IRCT20210823052264N2尚未招募3 期
Efficacy of Acyclovir in Pityriasis rosea, a double blind randomized controlled trial in a tertiary care hospital in Pakistan.
PNS SHIFA0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 70 years（—）
- 性别
- All
入选标准
- •Patients presenting with pityriasis rosea within first week of eruption of papulosquamous rash.
- •Either gender between Age 12-70 years.
排除标准
- •Positive venereal disease research laboratory (VDRL) test.
- •Females with pregnancy or lactation.
- •Patients who have taken any other specific treatment for PR in last 01 week.
- •Patients with any cause of immunosuppression like chronic renal failure, diabetes mellitus, HIV positive and malignancy etc.
研究者
相似试验
进行中（未招募）
不适用
Efficacy and Safety of Acyclovir Lipstick (Contra) in Treatment of Skin Infections Provoked by Herpes SimplexEUCTR2011-002135-26-ITAESCULAPIUS FARMACEUTICI S.R.L.
已完成
3 期
Treatment of pityriasis rosea, a skin rash, with antiviral drug acyclovirCTRI/2012/09/002995KLM Laboratories Pvt Ltd Provided acyclovir tablets and placebo tablets only30
已完成
4 期
8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis VersicolorPityriasis VersicolorNCT06170333Universitas Padjadjaran42
尚未招募
3 期
Effectiveness of Oral Acyclovir in Treatment of Infectious Mononucleosis in ChildreInfectious Mononucleosis.Cytomegaloviral mononucleosis, without complicationsB27.10IRCT20201201049554N1Gorgan University of Medical Sciences46
已完成
不适用
Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical TrifluridineHerpes SimplexHIV InfectionsNCT00000635National Institute of Allergy and Infectious Diseases (NIAID)25